{
  "ticker": "JNJ",
  "target_date": "2025-08-25",
  "actual_date": "2025-08-25",
  "collected_at": "2025-12-08T12:11:06.019994",
  "price": {
    "open": 177.09,
    "high": 177.82,
    "low": 175.87,
    "close": 175.99258422851562,
    "volume": 6229100,
    "change_1d_pct": -0.49,
    "change_7d_pct": 2.11,
    "change_30d_pct": 13.77
  },
  "technicals": {
    "rsi_14": 80.46,
    "sma_20": 170.98,
    "sma_50": 161.84,
    "macd": 4.128,
    "macd_signal": 4.033,
    "macd_histogram": 0.095,
    "bb_upper": 179.6,
    "bb_lower": 162.36,
    "price_vs_sma20_pct": 2.93,
    "price_vs_sma50_pct": 8.75,
    "volume_ratio": 0.73
  },
  "fundamentals": {
    "market_cap": 488062943232,
    "pe_ratio": 19.553572,
    "forward_pe": 19.110847,
    "price_to_book": 6.1485114,
    "price_to_sales": 5.296454,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.52,
    "pct_from_52w_low": 44.0
  },
  "macro": {
    "spy": {
      "price": 640.69,
      "change_1d_pct": -0.44,
      "change_7d_pct": -0.15
    },
    "vix": {
      "level": 14.79,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 98.43
    },
    "gold": {
      "price": 3373.8
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Take the Zacks Approach to Beat the Markets: WisdomTree, SkyWest & PepsiCo in Focus",
      "source": "Yahoo",
      "datetime": 1756131600,
      "summary": "Zacks highlights gains for WisdomTree, SkyWest, and PepsiCo as its stock strategies deliver strong returns amid market volatility.",
      "url": "https://finnhub.io/api/news?id=3ed18b6a289edc19dc1d552d15fb095d93c96a6e71b6acae983fea90fbb4dbf2"
    },
    {
      "headline": "J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?",
      "source": "Yahoo",
      "datetime": 1756125540,
      "summary": "Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.",
      "url": "https://finnhub.io/api/news?id=7a61db6e60664597f78faef55d9548619d5ef7aea98ac78bdc59054f01ff985c"
    },
    {
      "headline": "5 Blue-Chip Stocks to Buy as the Dow Achieves New Milestones",
      "source": "Yahoo",
      "datetime": 1756122240,
      "summary": "JPM, GS, JNJ, DIS, and MSFT are five blue-chip stocks that stand out with strong growth drivers and upgraded estimates as the Dow hits record highs.",
      "url": "https://finnhub.io/api/news?id=d9be021164336ad3ce81615d46728910670d9a2ba788bea740a869d35574ee6b"
    },
    {
      "headline": "[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Gro",
      "source": "Yahoo",
      "datetime": 1756121400,
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Targeted Drug Delivery Market size & share revenue was valued at approximately USD 9.8 Billion in 2024 and is expected to reach USD 11.4 Billion in 2025 and is expected ",
      "url": "https://finnhub.io/api/news?id=ef4ddda3f0dbf2ab2312eed9c2e9350218a2f35ab69a2e7b7f5d813f53ba6026"
    },
    {
      "headline": "How Recent Pharma Tariff Delays Could Impact J&J\u2019s Share Price in 2025",
      "source": "Yahoo",
      "datetime": 1756116841,
      "summary": "If you are standing at a crossroads with Johnson & Johnson's stock, you are not alone. The past several months have given investors plenty to think about, especially as J&J continues to find its footing amid policy headlines and global market shifts. The stock recently closed at $179.29, reflecting ",
      "url": "https://finnhub.io/api/news?id=f0ce60dc389c99916c3a6aaedf9acab5a4ddc51e97e05eeceb9cec5e945b4ca4"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-25",
      "description": "xslF345X05/wk-form4_1756163533.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000182/xslF345X05/wk-form4_1756163533.xml"
    },
    {
      "form": "4",
      "date": "2025-08-18",
      "description": "xslF345X05/wk-form4_1755555550.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}